To the Editor: Warts caused by the human papillomavirus are common. The prevalence of cutaneous warts in children varies (3.3% to 33%).1 As warts are contagious and cosmetically discomforting, patients often seek information regarding warts on the internet. YouTube has become a popular source of medical information.2-4 In this study, we aimed to analyze the characteristics, quality, and…

To the Editor: The American Joint Committee on Cancer 8th Edition (AJCC8) stages localized melanomas by tumor thickness and ulceration.1 However, the specific role of tumor thickness and ulceration in early-stage melanoma recurrence prediction using machine learning remains understudied. We leveraged a multi-institutional cohort of early-stage melanomas to evaluate the impact of stage-related…

To the Editor: Injection site reactions (ISRs) are localized reactions ranging from erythema, pruritus, and pain at the injection site.1 However, real-world data on ISRs to various biologics are limited, and ISRs to those used to treat moderate to severe psoriasis can affect treatment compliance.

Atopic dermatitis (AD) is a chronic, inflammatory skin disease commonly onset during infancy.

To the Editor: Hidradenitis suppurativa (HS) is a chronic inflammatory disease with significant morbidity. Studies have suggested an association between HS and metabolic syndrome,1 a risk factor for numerous liver pathologies. However, whether HS is independently associated with liver disease remains unclear.2,3 Herein, we aim to resolve this discrepancy through a systematic review and…

To the Editor: Epidermolysis bullosa (EB) is a rare, genetic, blistering disease that has no specific treatments. Trials are underway to compare new treatments with supportive care. Despite this, there is a lack of long-term objective data on how lesions change over time. We have used the validated Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) at each visit of our patients…

Prevalence of vaginal involvement in erosive lichen planus and pemphigus vulgaris has been reported in over 58% and up to 44% of patients, respectively.1,2 While most dermatologists are comfortable utilizing ultrapotent steroids on the vulva, less are comfortable with managing vaginal inflammation.